Progressive, Asana And Some Other Big Stocks Moving Lower On Thursday
U.S. stocks traded lower, with the Dow Jones gaining more than 100 points on Thursday. Here are some big stocks recording losses in today’s session.
This Analyst Slashes Price Target On Colgate-Palmolive? Plus Barclays Sees $78 For General Electric
Wells Fargo cut the price target for Colgate-Palmolive Company (NYSE: CL) from $80 to $75. Colgate-Palmolive shares rose 0.8% to trade at $70.84 on Monday.
MoffettNathanson Initiates Coverage On Asana with Market Perform Rating, Announces Price Target of $26
MoffettNathanson analyst Jackson Ader initiates coverage on Asana (NYSE:ASAN) with a Market Perform rating and announces Price Target of $26.
Tesla, Meta, NVIDIA And Other Big Losers From Tuesday
U.S. stocks closed sharply lower with the Nasdaq Composite dipping more than 5% on Tuesday. Here is the list of some big stocks moving lower in the previous session.
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
Gainers
Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX dose groups.
Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis.
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
Gainers
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.
NIO, Lucid Group And Other Big Gainers From Monday
U.S. stocks closed higher with the Dow Jones surging more than 200 points on Monday. Here is the list of some big stocks moving higher in the previous session.
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday’s Mid-Day Session
Gainers
Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
$350 Million Bet On This Technology Stock? 3 Stocks Insiders Are Buying
Although US stocks closed higher on Friday, there were a few notable insider trades.